Driven by the ongoing pace of innovation and sufficient financial support from investors, the CAR-T cell therapy market is anticipated to witness substantial growth in the foreseen future
The financial opportunity within the CAR-T cell therapy market has been analyzed across the following segments:
- Target Indication(s)
- Non-Hodgkin’s Lymphoma
- Multiple Myeloma
- Acute Lymphoblastic Leukemia
- Chronic Lymphocytic Leukemia
- Hodgkin’s Lymphoma
- Acute Myeloid Leukemia
- Ovarian Cancer
- Generalized Myasthenia Gravis (MG)
- Renal Cell Carcinoma
- Target Antigen
- CD19
- BCMA
- CD19/22
- Others
- Key Geographical Regions
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and North Africa
- Rest of the World
The Global CAR-T Cell Therapy Market (4th Edition), 2022-2035 report features the following companies, which we identified to be key players in this domain:
- Autolus
- bluebird Bio
- Bristol Myers Squibb
- Carsgen Therapeutics
- Cellectis
- Cellular Biomedicine Group
- Gilead Sciences
- Innovative Cellular Therapeutics
- Kuur Therapeutics
- Noile-Immune Biotech
- Novartis
- Shanghai GeneChem
- Sinobioway Cell Therapy
- Takara Bio
- Wellington Zhaotai Therapies
Table of Contents
- Preface
- Executive Summary
- Introduction
- CAR-T Cell Therapies: Market Landscape
- Key Insights
- Clinical Trial ANALYSIS
- Key Opinion Leaders
- CAR-T Cell Therapy Profiles
- Partnerships And Collaborations
- Funding And Investment Analysis
- Patent Analysis
- Case Study: Cell Therapy Manufacturing
- Cost Price Analysis
- Market Forecast and Opportunity Analysis
- Promotional Analysis
- Company Profiles
- Concluding Remarks
- Executive Insights
- Appendix 1: Tabulated Data
- Appendix 2: List of Companies and Organizations
Get more details on the CAR-T Cell Therapy Market report https://www.rootsanalysis.com/reports/view_document/car-t-therapies-market/269.html
You may also be interested in the following titles:
You may also like to learn what our experts are sharing in Roots educational series:
Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic? |
Exploring How Artificial Intelligence Is Transforming Digital Pathology |
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
